This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Zacks.com featured highlights include Tesla, PAM Systems, Unum Group, LPL Financial Holdings and CSX
by Zacks Equity Research
Tesla, PAM Systems, Unum Group, LPL Financial Holdings and CSX are part of Zacks Screen of the Week article.
5 Stocks With Solid Sales Growth to Buy Amid Market Turmoil
by Swayta Shah
Steady sales growth is the key to survival for a business, even during recessions. Let's check at Tesla (TSLA), EPAM Systems (EPAM), Unum (UNM), LPL Financial (LPLA) and CSX Corp (CSX) that are recording top-line growth.
Roper (ROP) Inks $3.73B Deal to Acquire Frontline Education
by Zacks Equity Research
Roper's (ROP) impeding acquisition of Frontline Education builds on its Horizon software business, expanding its presence in the K-12 education market.
Here's Why Epam (EPAM) Is a Great 'Buy the Bottom' Stock Now
by Zacks Equity Research
Epam (EPAM) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Here's How Much You'd Have If You Invested $1000 in Epam a Decade Ago
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
4 Giant Converging U.S. Tech Groups
by John Blank
Can 4 monster U.S. tech groups keep the S&P500 afloat?
How to Find Strong Buy Computer and Technology Stocks Using the Zacks Rank
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
Big Box U.S. Retail Reports: Global Week Ahead
by John Blank
Investors will be looking out for what the biggest U.S. retailers have to say on rising prices, after a rare bit of good news on inflation in the past week.
If You Invested $1000 in Epam a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
EPAM Soars 12% as Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
EPAM's Q2 results reflect the benefits of the ongoing digital transformation and a continued focus on customer engagement and product development.
Epam (EPAM) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Epam (EPAM) delivered earnings and revenue surprises of 39.18% and 4.39%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Dynatrace (DT) Matches Q1 Earnings Estimates
by Zacks Equity Research
Dynatrace (DT) delivered earnings and revenue surprises of 0% and 1.72%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Stem, Inc. (STEM) Soars 22.5%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Stem, Inc. (STEM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
ASGN or EPAM: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ASGN vs. EPAM: Which Stock Is the Better Value Option?
Is Invesco S&P 500 Equal Weight Technology ETF (RYT) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RYT
Should You Invest in the Invesco S&P 500 Equal Weight Technology ETF (RYT)?
by Zacks Equity Research
Sector ETF report for RYT
DOX vs. EPAM: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
DOX vs. EPAM: Which Stock Is the Better Value Option?
Strength Seen in ASGN Inc (ASGN): Can Its 6% Jump Turn into More Strength?
by Zacks Equity Research
ASGN Inc (ASGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
DOX vs. EPAM: Which Stock Is the Better Value Option?
by Zacks Equity Research
DOX vs. EPAM: Which Stock Is the Better Value Option?
DOX vs. EPAM: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
DOX vs. EPAM: Which Stock Is the Better Value Option?
EPAM Jumps 11% as Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
EPAM Systems' (EPAM) Q1 performance reflects its resiliency amid massive business disruptions caused by the Ukraine crisis, including the discontinuation of operations in Russia.
Epam (EPAM) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Epam (EPAM) delivered earnings and revenue surprises of 33.87% and 14.26%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
EPAM Systems (EPAM) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Though the accelerated digital modernization across industries is likely to aid EPAM Systems' (EPAM) Q1 results, the discontinuation of Russian operations is likely to have hurt the top and bottom lines.
ASGN vs. EPAM: Which Stock Is the Better Value Option?
by Zacks Equity Research
ASGN vs. EPAM: Which Stock Is the Better Value Option?
Epam (EPAM) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Epam (EPAM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.